BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24191512)

  • 1. Estimated breast cancer risk and screening outcomes among premenopausal women with non-cyclic mastalgia.
    Rogulski L; Bińczyk J
    Ginekol Pol; 2013 Sep; 84(9):754-7. PubMed ID: 24191512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
    Zhang L; Jie Z; Xu S; Zhang L; Guo X
    Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    Niell BL; Augusto B; McIntyre M; Conley CC; Gerke T; Roetzheim R; Garcia J; Vadaparampil ST
    AJR Am J Roentgenol; 2021 Jul; 217(1):48-55. PubMed ID: 33978450
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of 1294 Female Patients with Breast Pain: A Retrospective Study.
    Altıntas Y; Bayrak M
    Adv Ther; 2018 Sep; 35(9):1411-1419. PubMed ID: 30094702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in Breast Cancer Risk Model Estimates Among Women in Their 40s Seen in Primary Care.
    Schonberg MA; Karamourtopoulos M; Pinheiro A; Davis RB; Sternberg SB; Mehta TS; Gilliam EA; Tung NM
    J Womens Health (Larchmt); 2022 Apr; 31(4):495-502. PubMed ID: 35073183
    [No Abstract]   [Full Text] [Related]  

  • 6. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
    Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
    Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
    Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
    Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
    Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
    JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis between the Gail, Tyrer-Cuzick and BRCAPRO Models for Breast Cancer Screening in Brazilian Population.
    Stevanato KP; Pedroso RB; Iora P; Santos LD; Pelloso FC; Melo WA; Carvalho MDB; Pelloso SM
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3407-3413. PubMed ID: 31759366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.
    Amir E; Evans DG; Shenton A; Lalloo F; Moran A; Boggis C; Wilson M; Howell A
    J Med Genet; 2003 Nov; 40(11):807-14. PubMed ID: 14627668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study.
    Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1187-1194. PubMed ID: 31015199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire.
    Vianna FSL; Giacomazzi J; Oliveira Netto CB; Nunes LN; Caleffi M; Ashton-Prolla P; Camey SA
    Genet Mol Biol; 2019; 42(1 suppl 1):232-237. PubMed ID: 31170278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with screening recommendations according to breast cancer risk levels in Izmir, Turkey.
    Acikgoz A; Ergor G
    Asian Pac J Cancer Prev; 2013; 14(3):1737-42. PubMed ID: 23679266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer Risk in Sexual Minority Women during Routine Screening at an Urban LGBT Health Center.
    Clavelle K; King D; Bazzi AR; Fein-Zachary V; Potter J
    Womens Health Issues; 2015; 25(4):341-8. PubMed ID: 26060123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
    Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
    J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
    Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early results of breast cancer screening research].
    Nowicki A; Stogowska I
    Ginekol Pol; 2007 Jun; 78(6):464-70. PubMed ID: 17899703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.